Home Cart Sign in  
Chemical Structure| 1353859-00-3 Chemical Structure| 1353859-00-3

Structure of CX-6258 HCl
CAS No.: 1353859-00-3

Chemical Structure| 1353859-00-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

CX-6258 HCl is a potent, orally efficacious pan-Pim kinase inhibitor with IC50 of 5 nM, 25 nM and 16 nM for Pim1, Pim2, and Pim3, respectively.

Synonyms: CX-6258 hydrochloride

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of CX-6258 HCl

CAS No. :1353859-00-3
Formula : C26H25Cl2N3O3
M.W : 498.40
SMILES Code : O=C1NC2=C(C=C(Cl)C=C2)/C1=C\C3=CC=C(C4=CC=CC(C(N5CCN(C)CCC5)=O)=C4)O3.[H]Cl
Synonyms :
CX-6258 hydrochloride
MDL No. :MFCD28137787
InChI Key :YYIMMVXTWBIEAG-YHLMHSEJSA-N
Pubchem ID :72201040

Safety of CX-6258 HCl

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of CX-6258 HCl

epigenetics
JAK-STAT

Isoform Comparison

Biological Activity

Target
  • Pim3

    Pim3, IC50:16 nM

  • Pim1

    Pim1, IC50:5 nM

  • Pim2

    Pim2, IC50:25 nM

In Vitro:

Cell Line
Concentration Treated Time Description References
MM1R cells 5µM 12 h Induced apoptosis, detected by PARP cleavage and Caspase 3 activation PMC6290736
PC3 prostate adenocarcinoma cells 452 nM Synergistic cell killing in combination with chemotherapeutics PMC4025662
MM1S cells 5µM 12 h Induced apoptosis, detected by PARP cleavage and Caspase 3 activation PMC6290736
HeLa cells 40 nM 48 h To study the effect of Pim1 knockdown on EV-A71 replication, results showed that Pim1 silencing significantly reduced viral RNA levels and viral titer. PMC6726883

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Nude mice MV-4-11 xenograft model Oral 50 or 100 mg/kg Once daily for 21 days 50 mg/kg dose produced 45% tumor growth inhibition (TGI) and a 100 mg/kg dose produced 75% TGI PMC4025662
NSG mice Myeloma xenograft mouse model Oral gavage 35 mg/kg Daily for 3 weeks Evaluated the anti-myeloma activity of CX-6258 in combination with lenalidomide, showing significant tumor growth inhibition PMC6290736
Mice Patient-derived xenograft models Oral gavage 100 mg/kg Four doses over 9 days Evaluate the antitumor efficacy of CX-6258 in combination with CX-5461 against CRPC subtypes, showing significant reduction in tumor volume PMC6351078

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.01mL

0.40mL

0.20mL

10.03mL

2.01mL

1.00mL

20.06mL

4.01mL

2.01mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories